Capitolis Liquid Global Markets LLC Acquires New Holdings in CME Group Inc. (NASDAQ:CME)

Capitolis Liquid Global Markets LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,000 shares of the financial services provider's stock, valued at approximately $6,735,000.

A number of other institutional investors also recently bought and sold shares of CME. Norges Bank purchased a new stake in CME Group in the fourth quarter valued at approximately $1,107,389,000. Price T Rowe Associates Inc. MD lifted its position in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of CME Group in the fourth quarter valued at about $871,063,000. Capital Wealth Planning LLC grew its position in shares of CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock valued at $565,671,000 after purchasing an additional 996,498 shares in the last quarter. Finally, Egerton Capital UK LLP purchased a new position in CME Group during the fourth quarter worth about $223,967,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Performance

CME Group stock traded up $2.36 during midday trading on Friday, hitting $284.35. The company's stock had a trading volume of 953,386 shares, compared to its average volume of 2,155,183. The company has a 50-day moving average price of $264.47 and a two-hundred day moving average price of $245.67. The company has a market cap of $102.47 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $2.50 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. CME Group's payout ratio is presently 50.30%.

Insider Activity

In other news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now directly owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director now directly owns 2,915 shares of the company's stock, valued at $790,781.20. This represents a 25.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,726 shares of company stock valued at $8,975,813 in the last ninety days. 0.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently commented on CME. Oppenheimer increased their target price on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Piper Sandler increased their target price on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Barclays increased their price objective on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 23rd. Finally, Bank of America boosted their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.